ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,505.00
-0.71%
US Tech 100
19,190.40
0.95%
Dow Jones
40,287.53
0.00%
Brent Oil
81.35
-1.13%
Bitcoin
67,420.48
-1.08%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU

  6. Ipsen SA (IPN) Quote

Ipsen SA

Ipsen SA (IPN)

EU
110.80
1.50
( 1.37% )
Updated: 07:45:04
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
110.80
Bid
110.70
Ask
110.90
Volume
12,242
109.90 Day's Range 110.90
99.70 52 Week Range 130.70
Market Cap
8.966B
Previous Close
109.30
Open
110.00
Last Trade
28
@
110.8
Last Trade Time
07:45:04
Financial Volume
-
VWAP
-
Average Volume (3m)
76,223
Shares Outstanding
82,029,421
Dividend Yield
1.08%
PE Ratio
14.10
Earnings Per Share (EPS)
7.86
Revenue
3.37B
Net Profit
644.4M

About Ipsen SA

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.ipsen.com
Headquarters
Boulogne-billancourt, Hauts-de-seine, Fra
Founded
1970
Ipsen SA is listed in the Pharmaceutical Preparations sector of the Euronext with ticker IPN. The last closing price for Ipsen was 109.30 €. Over the last year, Ipsen shares have traded in a share price range of 99.70 € to 130.70 €.

Ipsen currently has 82,029,421 shares outstanding. The market capitalization of Ipsen is 8.97 € billion. Ipsen has a price to earnings ratio (PE ratio) of 14.10.

IPN Latest News

More News

IPSEN - Buy-back programme - Art 5 of MAR - Week 28 - 2024

IPSEN - Buy-back programme - Art 5 of MAR - Week 28 - 2024 Aggregated presentation by day and by market Purchases of own shares from July 8th to 12th  2024       Name of the IssuerIdentity code of...

July 16 2024
UK Regulatory

IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 28 - 2024

IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 28 - 2024 Présentation agrégée par jour et par marché Déclaration des transactions sur actions propres...

July 16 2024
UK Regulatory

Ipsen and Foreseen Biotechnology announce exclusive global licensing agreement for antibody-drug conjugate with first-in-class potential

Exclusive global rights secured for development, manufacture and commercialization of FS001, completing final stages of pre-clinical development with first-in-class potentialFS001 targets a novel...

July 11 2024
GlobeNewswire Inc.

Ipsen et Foreseen Biotechnology annoncent la signature d’un accord exclusif de licence mondiale pour un conjugué anticorps-médicament doté d'un potentiel de première classe

Ipsen et Foreseen Biotechnology annoncent la signature d’un accord exclusif de licence mondiale pour un conjugué anticorps-médicament doté d'un potentiel de première classe Ipsen a obtenu les...

July 11 2024
UK Regulatory

Ipsen - June 2024 - Monthly information relative to the total number of voting rights and shares composing the share capital

Ipsen - June 2024 - Monthly information relative to the total number of voting rights and shares composing the share capital Monthly information relative to the total number of voting rights and...

July 09 2024
UK Regulatory

IPSEN - Buy-back programme - Art 5 of MAR - Week 27 - 2024

IPSEN - Buy-back programme - Art 5 of MAR - Week 27 - 2024 Aggregated presentation by day and by market Purchases of own shares from July 1st to 5th 2024       Name of the IssuerIdentity code of...

July 09 2024
UK Regulatory

Ipsen - Juin 2024 - Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social

Ipsen - Juin 2024 - Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social Information mensuelle relative au nombre total des droits de voteet...

July 09 2024
UK Regulatory

Half-year statement of IPSEN liquidity agreement - 2024 06 30

Half-year statement of IPSEN liquidity agreement - 2024 06 30 Half-year statement of IPSEN liquidity agreement with NATIXIS ODDO BHF PARIS, FRANCE, July 8, 2024 - Under the liquidity...

July 08 2024
GlobeNewswire Inc.

IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 26 - 2024

IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 26 - 2024 Présentation agrégée par jour et par marché Déclaration des transactions sur actions...

July 02 2024
GlobeNewswire Inc.

Ipsen étend sa collaboration et son accord de licence pour le développement de Cabometyx® dans le traitement des tumeurs neuroendocrines avancées sur la base des résultats positifs de l’essai de Phase III CABINET

Ipsen étend sa collaboration et son accord de licence pour le développement de Cabometyx® dans le traitement des tumeurs neuroendocrines avancées sur la base des résultats positifs de l’essai...

July 02 2024
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.4-0.359712230216111.2112.2109.260154110.56032011DE
4-3-2.63620386643113.8118.4107.274710112.64432268DE
12-2.3-2.03359858532113.1126.7107.276223117.12235152DE
265.55.22317188984105.3126.799.775734111.4313638DE
52-0.1-0.0901713255185110.9130.799.774686112.25375942DE
15624.328.092485549186.5130.77783366101.94672208DE
260-2.4-2.12014134276113.2130.734.210757688.35302898DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
SERVServe Robotics Inc
$ 10.59
(40.26%)
18.49M
NCPLNetcapital Inc
$ 0.1383
(32.98%)
22.91M
RRRichtech Robotics Inc
$ 1.95
(32.65%)
8.88M
DBVTDBV Technologies SA
$ 1.04
(23.81%)
49.6k
CISOCISO Global Inc
$ 0.7105
(19.41%)
1.67M
HUBCWHub Cyber Security Ltd
$ 0.0121
(-47.39%)
1.65k
XCURExicure Inc
$ 0.3902
(-27.08%)
201.46k
VVOSVivos Therapeutics Inc
$ 2.05
(-16.33%)
1
RYAAYRyanair Holdings PLC
$ 98.04
(-14.24%)
37.5k
SNTGSentage Holdings Inc
$ 2.14
(-13.71%)
21.08k
NCPLNetcapital Inc
$ 0.1383
(32.98%)
22.91M
SERVServe Robotics Inc
$ 10.59
(40.26%)
18.49M
RRRichtech Robotics Inc
$ 1.95
(32.65%)
8.88M
MAXNMaxeon Solar Technologies Ltd
$ 0.225
(4.36%)
3.24M
SQQQProShares UltraPro Short QQQ
$ 8.23
(-2.72%)
3.02M

Discussion

View Full Feed
Jaxxm Jaxxm 5 minutes ago
MAXN has 545 Million outstanding shares, increases every week. Moved to TKLF 42 million os posted net profit
MAXN TKLF
JLPTNG JLPTNG 5 minutes ago
****FOR NEWBIES****


$LWLG issuing more shares - Huge dilution and Lebbys whores liquidating - this company has zero value, no sales, no revenue, HUGE losses - they only way they are here is more dilution - pathetic


3 'Ds" to Lebbys strategy
LWLG
oystersnbeer oystersnbeer 5 minutes ago
https://www.youtube.com/watch?v=tegw25qqbAs

https://www.youtube.com/watch?v=KMWsYJxCK4I

https://qph.cf2.quoracdn.net/main-qimg-a96e7c0550efe46d396f0e8f8d916027
Batman412 Batman412 6 minutes ago
I’ll be happy if it sees 0012 again
TONR
LVerstee LVerstee 6 minutes ago
Then there should be zero delay. That money should be in today and we all should be seeing our funds.
ITUP
CanItBThisEZ2Make CanItBThisEZ2Make 6 minutes ago
BEST SELLERS RANK (BSR) IS 662 15 Estimated Sold on Amazon Since JULY 1 - 3RD Quarter 2024
https://investorshub.advfn.com/uimage/uploads/2024/4/24/cnxttVOS_5G_GIF.gif
https://www.amazon.com/Vos-RDGL5GX55-B-01-VOS-5G-Dongle/dp/B0C66KHZLP

NOTE: In theory, when BSR Value De
SRMX
timberwolf7 timberwolf7 7 minutes ago
Tomorrow morning is going to be one of those 'binary' events in the

baby bio tech world isn't it.
JAGX
HGilS HGilS 8 minutes ago
To all longs - have a wonderful week :-)
Getting closer to the next CC.
Chances of having a PR are getting higher on a daily basis. 5.08% to get a PR
ELTP
Monksdream Monksdream 8 minutes ago
Whoops, I did it, again
HEPA
Midwestrader Midwestrader 9 minutes ago
ROFLMAO!!! Holding short positions?!?!?! This POS CON JOB trades at 0.0001 you dip,how much lower can it go IF anyone was shorting?? Wow...your knowledge of how stock trading works is at a kindergarten level. Anyone spending ten seconds on OTC Markets can see the REAL shorting of any stock which mu
INND
shotsky shotsky 9 minutes ago
Vik has none, Jake was paid off with shares.
NSAV
Awl416 Awl416 9 minutes ago
STRATA Skin Sciences Announces Approval of XTRAC Momentum™ 1.0 Device in Japan
SSKN
jedijazz jedijazz 9 minutes ago
$CYCA: Cytta Corp (CYCA) offers CyttaCOMMS incident management system with real-time video & audio streams for ongoing, relevant, actionable intelligence for First Responders. CyttaCARES is a game-changer in ensuring the safety of children in educational institutions and beyond. www.cytta.com #OTCQB
CYCA
Awl416 Awl416 9 minutes ago
Pharma Two B Announces Plans to Go Public via Merger with Hepion Pharmaceuticals, Inc. and Concurrent $11.5 Million Private Placement
HEPA
jedijazz jedijazz 10 minutes ago
$CYCA: Cytta Corp (CYCA) offers CyttaCOMMS incident management system with real-time video & audio streams for ongoing, relevant, actionable intelligence for First Responders. CyttaCARES is a game-changer in ensuring the safety of children in educational institutions and beyond. www.cytta.com #OTCQB
CYCA
Minddoc7 Minddoc7 10 minutes ago
COINTELEGRAPH Article: Arkham transfers $487M ARKMs to Coinbase Prime for tax compliance.
by Amaka Nwaokocha July 21, 2024

" The transfer to Coinbase Prime is a strategic step for Arkham, aligning with the company’s commitment to regulatory adherence and robust security measur
COIN
TurboDiesel06 TurboDiesel06 11 minutes ago
https://x.com/TPSAsiaPacific/status/1815354855218909682?t=zV_3EJ9wnRNJr15Xb2bG_A&s=19
ICNM
WooptdooU WooptdooU 12 minutes ago
Notforlong(s) lebby and the marcinobody guy TOOK an ENTIRE quarter of cash burn from a company with zero revenue because the in the pocket bod (mostly the SHIP JUMPER) allowed it. Who does that?

They all sold and made millions off of fools like me and all the helplessly hopeful penny
LWLG
hedge_fun hedge_fun 12 minutes ago
Isn’t the issue the divers are needed……

to assist the device in the scan?

5 years ago this thing was said to be autonomous and more efficient than anything on the market.

https://investorshub.advfn.com/uimage/uploads/2020/2/23/dkqbrTinkerbell_2.0.PNG
SFRX
Mufaso Mufaso 12 minutes ago
IMO Oral obesity drugs most likely to succeed based on data so far are LLY’s Orforglipron, VKTX’s VK2735 and Roche’s CT-996.

Orforglipron which is the most advanced, has decent weight loss plus a tolerability profile “consistent with the class” . Results from orforglipron's phase 3 w
LLY VKTX
green maschine green maschine 12 minutes ago
Good morning HOLO. This looks good for a bounce.
HOLO
FDApproved FDApproved 13 minutes ago
Pluri’s CDMO to Manufacture Kadimastem’s Cell Therapy Candidates

https://www.contractpharma.com/contents/view_breaking-news/2024-07-18/pluris-cdmo-to-manufacture-kadimastems-cell-therapy-candidates/
CDMO

Your Recent History

EU
IPN
Ipsen
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved